Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

ADVIA Centaur BNP (B-type Natriuretic Peptide) Recalled by Siemens Healthcare Diagnostics, Inc. Due to In certain scenarios the ADVIA Centaur CP, XP...

Date: December 18, 2017
Company: Siemens Healthcare Diagnostics, Inc.
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Siemens Healthcare Diagnostics, Inc. directly.

Affected Products

ADVIA Centaur BNP (B-type Natriuretic Peptide), Catalog Numbers: 02816138 (100 tests), 02816634 (500 tests)

Quantity: 21,687

Why Was This Recalled?

In certain scenarios the ADVIA Centaur CP, XP and XPT immunoassay analyzers may exhibit reduced dilution recovery or become inoperable when used with Multi-Diluent 15 and certain lots of BNP and TSH3RUL Assays.

Where Was This Sold?

This product was distributed to 27 states: AL, CA, DE, GA, IL, IN, IA, KY, MA, MI, MS, MT, NV, NJ, NM, NY, NC, ND, OH, PA, RI, TN, TX, VA, WA, WV, WY

Affected (27 states)Not affected

About Siemens Healthcare Diagnostics, Inc.

Siemens Healthcare Diagnostics, Inc. has 452 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report